findmyKOL
Clinical trialNCT03843671UnknownPhase 2Interventional

Hyperbaric Radiation Sensitization of Head and Neck Cancers

SponsorNational Baromedical ServicesEnrollment400Squamous Cell Carcinoma of the Head and Neck
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

There is reason to believe that hyperbaric oxygen administered immediately prior to radiotherapy will prove beneficial for this cancer type and stage. The basis for this hypothesis is a review of several decades of published work, the conclusion of a recent (2018) Cochrane Review, and results of a Phase I trial.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Hotel Dieu Hospital of Levis

    Lévis, Quebec, Canada

United States
  • the Mayo Clinic

    Rochester, Minnesota, United States

    Robert Foote, MD
  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, United States

    Jay Buckey, MD
  • Prisma Health Richland Hospital

    Columbia, South Carolina, United States

    Lindsie Cone, MD
  • Wilford Hall Medical Facility

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Hyperbaric oxygen
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jul 2019
Primary completion
31 Dec 2022
Completion
31 Dec 2024
Last update posted
18 Feb 2019
Registered enrollment
400
Registry id
NCT03843671
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.